-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Regeneron Pharmaceuticals, Raises Price Target to $740

Benzinga·08/03/2026 18:43:43
Listen to the news
Citigroup analyst Geoff Meacham maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Neutral and raises the price target from $700 to $740.